about
Osteoporosis in Parkinson's disease.Osteoporosis after stroke: a review of the causes and potential treatments.Possible synergism of physical exercise and ghrelin-agonists in patients with cachexia associated with chronic heart failure.The potential impact of new effervescent alendronate formulation on compliance and persistence in osteoporosis treatment.Low doses amino-bisphosphonates stimulate keratinocytes growth inactivating glucocorticoid receptor.Cross-cultural validation of the Italian version of the Cumulated Ambulation Score.Multimodal Analgesia in Total Knee Arthroplasty: A Randomized, Double-Blind, Controlled Trial on Additional Efficacy of Periarticular Anesthesia.Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study.Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis.NO-dependent proliferation and migration induced by Vitamin D in HUVEC.Psychometric properties of the Cumulated Ambulation Score: a systematic reviewLymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-upBreast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of TrastuzumabDevelopment and validation of the Italian version of the Spinal Cord Independence Measure IIILow concentration amino-bisphosphonates stimulate human keratinocyte proliferation and in vitro wound healingDifferent vitamin D substrate-product relationship after oral vitamin D supplementation in familial benign hypercalcemia, primary hyperparathyroidism, and healthy controlsAcute pseudogout following intravenous neridronate for osteoporosis1α,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cellsCasting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patientsDifferent PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjectsExtensor hallucis longus transfer as an alternative to split transfer of the tibialis anterior tendon to correct equinovarus foot in hemiplegic patients without overactivity of tibialis anteriorDoes altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trialA Rare Cause of Back Pain During Pregnancy and Lactation: Management and TreatmentGut-Joint Axis: The Role of Physical Exercise on Gut Microbiota Modulation in Older People with OsteoarthritisEffects of essential amino acid supplementation and rehabilitation on functioning in hip fracture patients: a pilot randomized controlled trialTackling the diversity of breast cancer related lymphedema: Perspectives on diagnosis, risk assessment, and clinical managementBuccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional studySafety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity TreatmentMyostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary studyElectrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot studyVerteporfin-loaded mesoporous silica nanoparticles inhibit mouse melanoma proliferation in vitro and in vivoBone Muscle Crosstalk in Spinal Cord Injuries: Pathophysiology and Implications for Patients' Quality of Life
P50
Q34974235-BA1E8E92-EA52-4D12-BB64-1F3C8A58F1C1Q37538305-DE9FCD7C-4803-42E3-A8FC-96EFBBDA7BABQ38172031-B85A596D-707C-4CD3-80B6-8A46B0DA0D83Q38226482-0A5E42C6-32F7-41FF-A7F4-66AED95DAFB9Q39092384-C3552394-0FD6-45A2-ADB3-E7A06DB09B69Q39877739-0AA744B9-FBF4-423B-B64B-0C018348AF40Q40837921-EBB2B9A3-A9CF-4850-94A0-524F9EDA2051Q47278061-182618EB-5A16-4BAD-A091-905C203B1B65Q50927799-0DD671FC-FBDD-4B74-B8E6-88144AD52B69Q53594520-4E327AB4-3A4B-4CFE-9E2F-F172122F395FQ53636940-13B5A52F-737D-4968-A283-EC9C8C7C9C17Q57138200-4E454649-93ED-412A-BFA7-870823ED632DQ58795748-4998D406-8927-43ED-AF48-FC29ADDAD174Q64244867-28DC09FB-25F7-4D9B-86BC-C4B5FAABDDD4Q82781485-E5F8DCD3-8D74-41D1-9BE1-2F36A3B10EBFQ83059183-DDB112E4-21C1-48EC-A5F9-9F7558D3BFF0Q83395452-82ED2162-C079-4D1E-8018-5A9BCBA46528Q84150645-47D5D9A7-4881-4E5F-89C2-7D7DA451DEFEQ84403320-5644746A-9BD5-4F65-85E7-309AA431283CQ84509315-8E54B3B8-1576-4CE1-8BCA-33001EE3ADE9Q84749903-57F3AB86-F0F7-4F74-AD59-7D6E4A5052F8Q84961327-25ABAF21-3A80-471F-8686-97F304A4CCA2Q87000056-C207E74F-1DD3-4772-BEA4-F1C5B34C0D78Q87225239-C9CA135B-10E1-4A16-ABA7-9D1AB4B45126Q89879968-168DD4DA-57D6-4BA8-9200-4960BCE558F9Q90420586-B2B0E37D-3586-4BE8-8BB0-19E6BED68724Q90722157-B25D329F-3489-432F-9EEA-E6065A44DFD0Q91242213-E8682ED3-E7E5-4B89-AA30-345215A4399FQ91413341-4C616F9E-42EC-4015-90F4-28A274CAC683Q91985671-26094A0F-BBBF-40CC-8033-D5DF1221B561Q92954224-44DC0E96-B9A5-4917-8A12-05BCBECC7CEAQ93123674-19FE50B9-7578-448B-B462-7A87B9A842A9Q96233147-82448A56-DE3C-41A4-A929-F235BEAA9D70
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Marco Invernizzi
@en
Marco Invernizzi
@nl
type
label
Marco Invernizzi
@en
Marco Invernizzi
@nl
prefLabel
Marco Invernizzi
@en
Marco Invernizzi
@nl
P31
P496
0000-0001-5141-0681